564 related articles for article (PubMed ID: 28529927)
1.
Pietrocola G; Nobile G; Rindi S; Speziale P
Front Cell Infect Microbiol; 2017; 7():166. PubMed ID: 28529927
[TBL] [Abstract][Full Text] [Related]
2. Neutrophils in innate host defense against Staphylococcus aureus infections.
Rigby KM; DeLeo FR
Semin Immunopathol; 2012 Mar; 34(2):237-59. PubMed ID: 22080185
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases.
Zecconi A; Scali F
Immunol Lett; 2013 Feb; 150(1-2):12-22. PubMed ID: 23376548
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion.
Laarman AJ; Ruyken M; Malone CL; van Strijp JA; Horswill AR; Rooijakkers SH
J Immunol; 2011 Jun; 186(11):6445-53. PubMed ID: 21502375
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus evasion of innate antimicrobial defense.
Kraus D; Peschel A
Future Microbiol; 2008 Aug; 3(4):437-51. PubMed ID: 18651815
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcal innate immune evasion.
Rooijakkers SH; van Kessel KP; van Strijp JA
Trends Microbiol; 2005 Dec; 13(12):596-601. PubMed ID: 16242332
[TBL] [Abstract][Full Text] [Related]
7. Host defense and pathogenesis in Staphylococcus aureus infections.
DeLeo FR; Diep BA; Otto M
Infect Dis Clin North Am; 2009 Mar; 23(1):17-34. PubMed ID: 19135914
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses.
Jongerius I; von Köckritz-Blickwede M; Horsburgh MJ; Ruyken M; Nizet V; Rooijakkers SH
J Innate Immun; 2012; 4(3):301-11. PubMed ID: 22327617
[TBL] [Abstract][Full Text] [Related]
9. Bacterial evasion of innate host defenses--the Staphylococcus aureus lesson.
Fedtke I; Götz F; Peschel A
Int J Med Microbiol; 2004 Sep; 294(2-3):189-94. PubMed ID: 15493829
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections.
McAdow M; Missiakas DM; Schneewind O
J Innate Immun; 2012; 4(2):141-8. PubMed ID: 22222316
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus innate immune evasion is lineage-specific: a bioinfomatics study.
McCarthy AJ; Lindsay JA
Infect Genet Evol; 2013 Oct; 19():7-14. PubMed ID: 23792184
[TBL] [Abstract][Full Text] [Related]
12. Recognition of Staphylococcus aureus by the innate immune system.
Fournier B; Philpott DJ
Clin Microbiol Rev; 2005 Jul; 18(3):521-40. PubMed ID: 16020688
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus epidermidis strategies to avoid killing by human neutrophils.
Cheung GY; Rigby K; Wang R; Queck SY; Braughton KR; Whitney AR; Teintze M; DeLeo FR; Otto M
PLoS Pathog; 2010 Oct; 6(10):e1001133. PubMed ID: 20949069
[TBL] [Abstract][Full Text] [Related]
14. The chemerin-CMKLR1 axis in keratinocytes impairs innate host defense against cutaneous Staphylococcus aureus infection.
Chen Y; Song Y; Wang Z; Lai Y; Yin W; Cai Q; Han M; Cai Y; Xue Y; Chen Z; Li X; Chen J; Li M; Li H; He R
Cell Mol Immunol; 2024 Jun; 21(6):533-545. PubMed ID: 38532043
[TBL] [Abstract][Full Text] [Related]
15. Immune evasion by staphylococci.
Foster TJ
Nat Rev Microbiol; 2005 Dec; 3(12):948-58. PubMed ID: 16322743
[TBL] [Abstract][Full Text] [Related]
16. Molecular battle between host and bacterium: recognition in innate immunity.
Bardoel BW; Strijp JA
J Mol Recognit; 2011; 24(6):1077-86. PubMed ID: 22038814
[TBL] [Abstract][Full Text] [Related]
17. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils.
Voyich JM; Braughton KR; Sturdevant DE; Whitney AR; Saïd-Salim B; Porcella SF; Long RD; Dorward DW; Gardner DJ; Kreiswirth BN; Musser JM; DeLeo FR
J Immunol; 2005 Sep; 175(6):3907-19. PubMed ID: 16148137
[TBL] [Abstract][Full Text] [Related]
18. Recurrent infections and immune evasion strategies of Staphylococcus aureus.
Kim HK; Thammavongsa V; Schneewind O; Missiakas D
Curr Opin Microbiol; 2012 Feb; 15(1):92-9. PubMed ID: 22088393
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions.
Stemerding AM; Köhl J; Pandey MK; Kuipers A; Leusen JH; Boross P; Nederend M; Vidarsson G; Weersink AY; van de Winkel JG; van Kessel KP; van Strijp JA
J Immunol; 2013 Jul; 191(1):353-62. PubMed ID: 23740955
[TBL] [Abstract][Full Text] [Related]
20. Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood.
McAdow M; Kim HK; Dedent AC; Hendrickx AP; Schneewind O; Missiakas DM
PLoS Pathog; 2011 Oct; 7(10):e1002307. PubMed ID: 22028651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
